Joel Habener

Joel Habener
Joel Habener
Alma mater	David Geffen School of Medicine at UCLA; University of Redlands ;
Occupation	Endocrinologist
Awards	Warren Alpert Foundation Prize (for identifying glucagon-like peptides and leading the field with studies extending from cells to humans, culminating in the development of these peptides as therapeutic agents for treating diabetes and short bowel syndrome, 2020); Lasker–DeBakey Clinical Medical Research Award (2024) ;

Joel Habener is a Professor of Medicine at Harvard Medical School.

Quick Facts Alma mater, Occupation ...

Close

Habener worked with Svetlana Mojsov on elucidating the role of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2). Habener received credit for the work on hormones when Mosjov was not credited.^[1] Habener was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.^[2] He was elected to the National Academy of Sciences in 2020.^[3] In 2021, he was awarded the Canada Gairdner International Award.^[4] In 2023, he received the VinFuture Prize.^[5] In 2024, he was awarded the Princess of Asturias Awards for Technical and Scientific Research,^[6] the Tang Prize in the category of "Biopharmaceutical Science"^[7] and also in 2024 the Lasker Award^[8]^[9] for clinical research.

Remove ads

References

Joel Habener

Alma mater	David Geffen School of Medicine at UCLA University of Redlands
Occupation	Endocrinologist
Awards	Warren Alpert Foundation Prize (for identifying glucagon-like peptides and leading the field with studies extending from cells to humans, culminating in the development of these peptides as therapeutic agents for treating diabetes and short bowel syndrome, 2020) Lasker–DeBakey Clinical Medical Research Award (2024)